Windtree Therapeutics Inc (WINT)
0.5093
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.5091
0.00 (0.00%)
Pre-Market: 09:10
Windtree Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2019 | -4.07K% |
| March 31, 2019 | -16.34K% |
| December 31, 2018 | -2.97K% |
| September 30, 2018 | -1.71K% |
| June 30, 2018 | -290.4% |
| March 31, 2018 | -2.21K% |
| December 31, 2017 | |
| September 30, 2017 | -32.02K% |
| June 30, 2017 | -588.7% |
| March 31, 2017 | -3.98K% |
| December 31, 2016 | -733.6% |
| September 30, 2016 | -870.2% |
| June 30, 2016 | -10.02K% |
| March 31, 2016 | -18.53K% |
| December 31, 2015 | -1.54K% |
| September 30, 2015 | -32.66K% |
| June 30, 2015 | -15.10K% |
| March 31, 2015 | -6.38K% |
| December 31, 2014 | -898.2% |
| September 30, 2014 | -2.15K% |
| June 30, 2014 | -971.9% |
| March 31, 2014 | -37.02K% |
| December 31, 2013 | -16.07K% |
| September 30, 2013 | -20.37K% |
| June 30, 2013 | -4.74K% |
| Date | Value |
|---|---|
| March 31, 2013 | -17.55K% |
| December 31, 2012 | -3.49K% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | -4.02K% |
| March 31, 2011 | -1.01K% |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | -21.28K% |
| June 30, 2008 | -408.6% |
| March 31, 2008 | -473.9% |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | -16.29% |
| AIM ImmunoTech Inc | -10.57K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 18.02% |
| Armata Pharmaceuticals Inc | -- |